Patent · US Active

Therapeutic compounds

US8394794B2 · kind B2 · utility

0Cited by

1References

21Claims

0Family size

Assignee

Regents of the University of Minnesota · US

Inventors

Chengguo Xing · Gainesville, US
Jignesh Doshi · Pune, IN

Key dates

Filing date	Mar 21, 2008
Grant date	Mar 12, 2013
Priority date	—
Expiry date	Jul 24, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention provides compounds of Formula (I) and (IV): as described herein, as well as salts thereof. The compounds have anti-cancer properties and/or chemosensitization properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.